Deximafen

This classification denotes an antidepressant agent with the molecular formula C11H13N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1V5135S169, chemically known as 1h-imidazo(1,2-a)imidazole, 2,3,5,6-tetrahydro-3-phenyl-, ( )- but generally known as deximafen, which bears US NIH Compound Identifier 163316. European Medicines Agency schedules Deximafen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07031MIG. The term DEXIMAFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). DEXIMAFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule deximafen under HS 29339990 and SITC 51577. As of Q4 2014, DEXIMAFEN remains the US FDA Preferred Term for this commodity. Deximafen bears US NLM identifiers UMLS ID C2699611 and NCI Concept Code C78015. SMILES: C1CN2C(CN=C2N1)C3=CC=CC=C3.